Blog

Shares of biotech heavyweight Regeneron Pharmaceuticals (NASDAQ: REGN) lost 10% of their value over the first three and a half days of trading this week, according to data provided by S&P Global

Last year, Amazon (NASDAQ: AMZN) struggled with various economic headwinds, as well as other company-specific challenges. That led it to report its first annual loss in nearly a decade, and its

Large-cap pharmaceuticals stocks that pay dividends frequently generate market-beating returns over the long term. The core reason is that these companies tend to sport healthy profit margins

By all accounts, Thursday should have been a huge day for Virgin Galactic (NYSE: SPCE) -- but it's not working out that way at all, and as of 1:20 p.m. ET, shares of the space tourism pioneer are in

Shares of railroad freight car manufacturer Greenbriar Companies (NYSE: GBX) surged 25% through 11:30 a.m. ET on Thursday after crushing analyst earnings forecasts like, well, a freight train.

Bank stocks rose this week on seemingly good news out of PacWest Bancorp (NASDAQ: PACW) and as the large and super-regional banks breezed through the Federal Reserve's annual stress testing.

Shares

QuantumScape (NYSE: QS) shares jumped Thursday morning after its latest investor presentation yesterday. The stock moved up by almost 8% and remained higher by 4.9% at 12:05 p.m. ET. Today's move

Biotech heavyweight Amgen (NASDAQ: AMGN) will probably continue to be an active player in the merger and acquisition (M&A) scene, regardless of what happens with its proposed $28 billion buyout of

Failing to meet Wall Street's expectations, Lindsay (NYSE: LNN) reported third-quarter 2023 financial results this morning before markets opened, and investors aren't happy. Although management

Shares of CorMedix (NASDAQ: CRMD) were down more than 21% as of noon ET on Thursday. The shares fell after the company announced a stock sale. The healthcare stock is down more than 5% so far this

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Amazon wants to

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

AI has weaved

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Sony wants to

This month has been anecdotally soft for theme parks, and we'll get some more concrete data when the publicly traded operators report on their springtime quarters in a few weeks. SeaWorld

Shares of BioXcel Therapeutics (NASDAQ: BTAI) were down 62% at 11 a.m. on Thursday after the company announced phase 3 trial results for Alzheimer's disease–related agitation therapy BXCL501. The

Investors aren't thrilled about the short-term growth prospects for Etsy (NASDAQ: ETSY) stock right now. The e-commerce specialist has been going through a painful growth hangover that has pressured

If the country were to enter a severe recession, the Federal Reserve projects that the 23 largest banks operating in the U.S. would incur $541 billion of loan losses, for a total projected loss rate

While the S&P 500 and Dow Jones Industrial Average are both inching higher to start today's trading session, there's no doubt about investors' enthusiasm for Freyr Battery (NYSE: FREY). The stock is

Carnival (NYSE: CCL) has taken investors on a nauseating ride this week. Shares of the cruise operator plunged following the release of its second-quarter results earlier in the week.

However,

Investors are hungry for this month's hottest initial public offering (IPO). It's been two weeks since Cava Group (NYSE: CAVA) had its highly anticipated market debut. The rapidly expanding chain of

Warner Bros. Discovery (NASDAQ: WBD) is making headlines in 2023 for, among other things, the overhaul of its flagship streaming platform, cuts at Turner Classic Movie, dropping CNN ratings, and

The reigning king of Hollywood studios, Walt Disney (NYSE: DIS) hasn't been looking very powerful lately. The summer movie season is in full swing, but the company has taken a few big whiffs

Recent headlines might have you believing that you've missed the boat. The market's 20% rebound from its low has some calling this the end of the bear market even though the S&P 500 remains about 9%

In this video, I will talk about Robinhood (NASDAQ: HOOD), why Ark Invest recently sold shares of Tesla to buy Robinhood stock, and my reason behind opening a small position in the fintech company

Johnson & Johnson (NYSE: JNJ) is a company that may look a lot different over the next several years. Top-selling drug Stelara is facing a patent cliff this year, the company has just spun off one